Nabriva Hopes To Relaunch Xenleta In Community Setting As Pandemic Subsides

 
• By Joseph Haas
  
Antibiotic resistant bacteria closeup biofilm
Nabriva is betting that the market for antibiotics will bounce back in 2021

More from Strategy

More from Business